I  U  P  A  C






News & Notices

Organizations & People

Standing Committees

Divisions

Projects

Reports

Publications
..CI
..PAC
..Macro. Symp.

..Books
..Solubility Data

Symposia

AMP

Links of Interest

Search the Site

Home Page

 

Pure Appl. Chem., Vol. 72, No. 9, pp. 1783-1786, 2000.

 

Synthetic study of ravidomycin, a hybrid natural product*

Keisuke Suzuki

Department of Chemistry, Tokyo Institute of Technology, and CREST, JST, 2-12-1, O-okayama, Meguro-ku, Tokyo 152-8551, Japan

Abstract: Strategies and tactics associated with the total synthesis of hybrid natural products are discussed. The target is ravidomycin (2), one of the gilvocarcin-class antitumor antibiotics with an aryl C-glycoside structure. The first total synthesis of 2, which was achieved along similar lines of that of gilvocarcin V (1), served for the determination of the relative as well as the absolute stereochemistry of 2. Also revealed was a limitation of the synthetic scheme so long as the amino sugar congener was concerned. A preliminary result is discussed on the [2+2+2] approach that relies on the ready availability of various benzocyclobutene derivatives via regioselective [2+2] cycloaddition of a-alkoxybenzynes and ketene silyl acetals.

*Lecture presented at the 13th International Conference on Organic Synthesis (ICOS-13), Warsaw, Poland, 1-5 July 2000.

Back to Contents for access to full text


Page last modified 15 January 2001.
Copyright ©2000-2001 International Union of Pure and Applied Chemistry.
Questions or comments about IUPAC, please contact, the Secretariat.
Questions regarding the website, please contact web manager.